Generic drugs, cheaper than their brand-name counterparts, are crucial to reducing the high cost of prescription medicines for many patients. Though generics make up 89% of prescriptions , barriers exist to their market entry such as delays from practices like ‘evergreening’ and ‘pay-for-delay’ agreements. Policymakers could help by implementing strategies to reduce these barriers, speeding up review processes, promoting transparency, and encouraging more competition. This would help provide access to affordable and effective therapies for all.
PupkinStealer Attacks Windows System to Steal Login Credentials & Desktop Files
Cybersecurity researchers have discovered a new information-stealing malware named PupkinStealer. The malware, first identified in April 2025, steals browser credentials, messaging app sessions, and desktop
